500 West 5th Street
Suite 1200
Austin, TX 78703
United States
512 900 4690
https://www.shattucklabs.com
Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 85
Name | Title | Pay | Exercised | Year born |
---|---|---|---|---|
Dr. Taylor H. Schreiber M.D., Ph.D. | Co-Founder, CEO & Director | 744.45k | N/A | 1980 |
Dr. Arundathy Nirmalini Pandite M.B.A., M.D. | Chief Medical Officer | 638.44k | N/A | 1959 |
Ms. Casi DeYoung | Chief Bus. Officer | 523.48k | N/A | 1971 |
Mr. Andrew R. Neill M.B.A. | Chief Financial Officer | N/A | N/A | 1986 |
Dr. Abhinav A. Shukla Ph.D. | Chief Technical Officer | N/A | N/A | 1973 |
Mr. Conor Richardson CPA | VP of Investor Relations | N/A | N/A | N/A |
Ms. Erin Ator Thomson J.D. | Gen. Counsel, Corp. Sec. and Chief Ethics & Compliance Officer | N/A | N/A | 1980 |
Dr. Thomas Lampkin Pharm.D. | Sr. VP of Regulatory Affairs | N/A | N/A | N/A |
Ms. Fatima Rangwala M.D., Ph.D. | Sr. VP of Clinical Research | N/A | N/A | N/A |
Mr. George Fromm Ph.D. | Chief Scientific Officer of ARC Platform | N/A | N/A | N/A |
Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. It also develops SL-279252 that is in Phase 1 clinical trial in patients with advanced solid tumors and lymphoma. The company was incorporated in 2016 and is headquartered in Austin, Texas.
Shattuck Labs, Inc.’s ISS governance QualityScore as of 1 February 2023 is 7. The pillar scores are Audit: 7; Board: 5; Shareholder rights: 8; Compensation: 8.